Cytodyn Inc (CYDY)

[Saltz]

CYDY’s immediate future is riding on the read out from the 75 patient trial.

We are going to find out just how credible and accurate Dr. Patterson is. I will say he seems to be quite certain about what he is seeing coming through the IncellDx lab. It’s as if he can decipher through the bloodwork and determine who was administered placebo and who received Leronlimab.

If the data is as overwhelming skewed towards Letonlimab as Dr. Patterson would have us believe CYDY will be on it’s way to a sizeable government grant that will provide the capital to uplist. If not - well I don’t even want to go there. There is much riding on this so very important trial.

My one reservation that causes me to pause is Nader’s reluctance to address the number of patients currently enrolled. He sidestepped that question with Christine in the last PI interview. With the number of prospective patients that are infected this trial should be fully enrolled. Don’t tell listeners on Tuesday that we are still at 45 patients with a laundry list of excuses.

I have been Long for eight years and patiently observed Nader’s personality and ability to execute. The science is in a league all it’s own. Nader’s effectiveness and street cred is unfortunately not of the same caliber.

I am very interested in what he has in store for us on Tuesday. I’m looking for some real substance.